Spero Therapeutics, Inc. (SPRO)
Pre-market:
| Previous close | 1.4700 |
| Open | 1.4700 |
| Bid | 1.4700 x 100 |
| Ask | 1.5400 x 100 |
| Day's range | 1.4700 - 1.5300 |
| 52-week range | 0.9900 - 1.9950 |
| Volume | |
| Avg. volume | 322,461 |
| Market cap | 80.839M |
| Beta (5Y monthly) | 0.57 |
| PE ratio (TTM) | 3.49 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
14 Cheap Penny Stocks to Buy According to Analysts
In this article, we will take a detailed look at the 14 Cheap Penny Stocks to Buy According to Analysts. For a quick overview of such stocks, read our article 5 Cheap Penny Stocks to Buy According to Analysts. The US stock market is going through a pullback as optimism around rate cuts fades. The AI-led rally that boosted […]
- Simply Wall St.
Spero Therapeutics, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
It's been a good week for Spero Therapeutics, Inc. ( NASDAQ:SPRO ) shareholders, because the company has just released...
- Insider Monkey
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2023 Earnings Call Transcript
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2023 Earnings Call Transcript March 13, 2024 Spero Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.96, expectations were $-0.1. SPRO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to the […]
